formaldehyde and alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol

formaldehyde has been researched along with alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beitz, AJ; Han, HJ; Kim, HW; Kim, KW; Kwon, YB; Lee, JH; Roh, DH; Yoon, SY1

Other Studies

1 other study(ies) available for formaldehyde and alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol

ArticleYear
Intrathecal treatment with sigma1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice.
    British journal of pharmacology, 2006, Volume: 148, Issue:4

    Topics: Animals; Ethylenediamines; Formaldehyde; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Motor Activity; Pain Measurement; Phosphorylation; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Pyrimidines; Receptor, Serotonin, 5-HT1A; Receptors, N-Methyl-D-Aspartate; Receptors, sigma

2006